Category: Drug Discovery

Is AI Failing Drug Development? The Unseen Challenges Noam Solomon, CEO at Immunai For over a decade, we’ve heard about…

NVIDIA Collaborates with IQVIA, Illumina, and Mayo Clinic to Drive Drug Discovery What You Should Know:  – NVIDIA announced collaborations…

Pepticom Secures $6.6M to Advance AI-Powered Peptide Drug Discovery What You Should Know:  – Pepticom, an innovator in AI-driven peptide-based…

M&A: Predictive Oncology to be Acquired by Renovaro What You Should Know:  – Predictive Oncology Inc. (NASDAQ: POAI), a leader…

BrightInsight, Sanofi to Build Drug Companion Apps for its Major Specialty Therapies What You Should Know:  – BrightInsight, Inc., a…

GeneDx Launches AI Tool to Fuel Rare Disease Drug Discovery What You Should Know:  – GeneDx, a leader in genomic…

NVIDIA BioNeMo Framework Accelerates AI Drug Discovery What You Should Know:  – NVIDIA announced widespread adoption of its open-source BioNeMo™…

Accenture Invests in 1910 Genetics to Accelerate AI-Powered Drug Discovery What You Should Know:  – Accenture has made a strategic…

Gilead Sciences and Genesis Therapeutics Partner on AI-Driven Drug Discovery What You Should Know:  – Gilead Sciences, a global biopharmaceutical…

The Role of AI in Streamlining Drug Discovery and Clinical Trials: A New Era in Pharmaceutical Innovation In the rapidly…